Advancing ovarian cancer research

Ovarian cancer is often diagnosed late, making it the deadliest gynecologic cancer. Each year, over 20,000 women in the U.S. are diagnosed, and the five-year survival rate is only 49%. The Ovarian Cancer Research Alliance (OCRA) funds groundbreaking research to improve early detection and treatment. They also provide support services for patients and families navigating this disease. To learn more about OCRA, visit https://ocrahope.org. Your order helps fund research that can save lives.